HuGE Literature Finder
Records 1-15
|
Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features.
Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
|
Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Human pathology 2019 Mar . Park Ha Young, Kwon Mi Jung, Kang Ho Suk, Kim Yun Joong, Kim Nan Young, Kim Min Jeong, Min Kyueng-Whan, Choi Kyung Chan, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Choe Ji-Young, Lee Hye Kyu |
|
Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma.
Cancers 2019 Jan 11 (1): . Jungk Christine, Warta Rolf, Mock Andreas, Friauf Sara, Hug Bettina, Capper David, Abdollahi Amir, Debus Jürgen, Bendszus Martin, von Deimling Andreas, Unterberg Andreas, Herold-Mende Christ |
|
Overexpression of miR-216b: prognostic and predictive value in acute myeloid leukemia.
Journal of cellular physiology 2017 Sep . Zhang Ting-Juan, Wu De-Hong, Zhou Jing-Dong, Li Xi-Xi, Zhang Wei, Guo Hong, Ma Ji-Chun, Deng Zhao-Qun, Lin Jiang, Qian J |
|
Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
British journal of haematology 2016 Jul . Shiba Norio, Yoshida Kenichi, Shiraishi Yuichi, Okuno Yusuke, Yamato Genki, Hara Yusuke, Nagata Yasunobu, Chiba Kenichi, Tanaka Hiroko, Terui Kiminori, Kato Motohiro, Park Myoung-Ja, Ohki Kentaro, Shimada Akira, Takita Junko, Tomizawa Daisuke, Kudo Kazuko, Arakawa Hirokazu, Adachi Souichi, Taga Takashi, Tawa Akio, Ito Etsuro, Horibe Keizo, Sanada Masashi, Miyano Satoru, Ogawa Seishi, Hayashi Yasuhi |
|
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
|
Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.
Oncology letters 2015 Dec 10 (6): 3599-3606. Franceschi Sara, Mazzanti Chiara M, Lessi Francesca, Aretini Paolo, Carbone Francesco G, LA Ferla Marco, Scatena Cristian, Ortenzi Valerio, Vannozzi Riccardo, Fanelli Giovanni, Pasqualetti Francesco, Bevilacqua Generoso, Zavaglia Katia, Naccarato Antonio |
|
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Oncotarget 2015 Nov . Gao Ke, Li Gang, Qu Yiping, Wang Maode, Cui Bo, Ji Meiju, Shi Bingyin, Hou Pe |
|
Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Oncotarget 2015 Sep . Li Rui, Chen Xincheng, You Yongping, Wang Xiefeng, Liu Yanwei, Hu Qi, Yan W |
|
Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015 Sep 22 (9): 1425-9. Kong Doo-Sik, Kim Hong Rye, Choi Yoon-Ra, Seol Ho Jun, Lee Jung-Il, Nam Do-Hy |
|
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.
PloS one 2015 10 (11): e0142750. Nakae Shunsuke, Sasaki Hikaru, Hayashi Saeko, Hattori Natsuki, Kumon Masanobu, Nishiyama Yuya, Adachi Kazuhide, Nagahisa Shinya, Hayashi Takuro, Inamasu Joji, Abe Masato, Hasegawa Mitsuhiro, Hirose Yuic |
|
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
|
Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival.
PloS one 2013 8 (6): e67421. Yao Yu, Chan Aden Ka-Yin, Qin Zhi Yong, Chen Ling Chao, Zhang Xin, Pang Jesse Chung-Sean, Li Hiu Ming, Wang Yin, Mao Ying, Ng Ho-Keung, Zhou Liang |
|
Correlation between IDH1 Gene Mutation Status and Survival of Patients Treated for Recurrent Glioma.
Anticancer research 2011 Dec 31 (12): 12. Lv S, Teugels E, Sadones J, Quartier E, Huylebrouck M, DU Four S, LE Mercier M, DE Witte O, Salmon I, Michotte A, DE Grève J, Neyns B |
|
Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
Neurology India 0 66 (6): 1726-1731. Geevar Tulasi, Pai Rekha, Chacko Geeta, Malepathi Karthik, Patel Bimal, John Jacob, Chacko Ari G, Balakrishnan Rajesh, John Subashi |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 12, 2021
- Content source: